CRSP

#1107
CRISPR Therapeutics AG - Common Shares
56.1 8 USD
-0.35%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
56.18
56.18
년간 변동
35.48
78.48
일일 변동
-0.35%
월간 변동
+9.47%
6달 변화
+7.42%
년간 변동율
+52.25%
이전 종가
56.3 8
Open
56.1 8
저가
56.1 8
High
56.1 8
양
132
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
손익계산서 대차대조표 현금 흐름
값 202020212022202320242025 TTM

CRISPR Therapeutics AG - Common Shares

CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023.

뉴스